VISTAGEN THERAPEUTICS, INC. Deferred Tax Assets, Operating Loss Carryforwards, Domestic
VISTAGEN THERAPEUTICS, INC. (VTGN) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $39.18 million as of 2021-03-31, per its 10-K filed 2021-06-29.
Discontinued › Notes › Components of Deferred Tax Assets › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2021-06-29
- 2021-03-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $39.18M.
- 2018-03-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $88.48M.
- 2017-03-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $77.10M.
- 2016-03-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $67.90M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic |
|---|---|
| 2021-03-31 | $39.18M 10-K · filed 2021-06-29 |
| 2018-03-31 | $88.48M 10-K · filed 2018-06-26 |
| 2017-03-31 | $77.10M 10-K · filed 2017-06-29 |
| 2016-03-31 | $67.90M 10-K · filed 2016-06-24 |
| 2015-03-31 | $58.70M 10-K · filed 2015-06-29 |
| 2014-03-31 | $50.30M 10-K · filed 2014-06-25 |
| 2013-03-31 | $47.90M 10-K · filed 2013-07-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |